Constellation Brands, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Derivative Instruments

Derivative Instruments

9 Months Ended

Nov. 30, 2018

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS

DERIVATIVE INSTRUMENTS:

Overview –

Our risk management and derivative accounting policies are presented in Notes 1 and 6 of our consolidated financial statements included in our 2018 Annual Report and have not changed significantly for the nine months and three months ended November 30, 2018. In addition, we have investments in certain equity securities which provide us with the option to purchase an additional ownership interest in the equity securities of that issuer (see Note 8). These investments are included in other assets and are accounted for at fair value, with the net gain (loss) from the changes in fair value of these investments recognized in income (loss) from unconsolidated investments (see Note 5).

The aggregate notional value of outstanding derivative instruments is as follows:



	November 30, 2018		February 28, 2018
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts	$	1,598.7	$	1,465.4

Derivative instruments not designated as hedging instruments
Foreign currency contracts	$	356.8	$	440.6
Commodity derivative contracts	$	260.2	$	177.5

Credit risk –

We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the derivative contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association agreements which allow for net settlement of the derivative contracts. We have also established counterparty credit guidelines that are regularly monitored. Because of these safeguards, we believe the risk of loss from counterparty default to be immaterial.

In addition, our derivative instruments are not subject to credit rating contingencies or collateral requirements. As of November 30, 2018, the estimated fair value of derivative instruments in a net liability position due to counterparties was $65.8 million. If we were required to settle the net liability position under these derivative instruments on November 30, 2018, we would have had sufficient available liquidity on hand to satisfy this obligation.

Results of period derivative activity –

The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 5):



Assets					Liabilities
	November 30, 2018		February 28, 2018			November 30, 2018		February 28, 2018
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	4.8	$	21.2	Other accrued expenses and liabilities	$	34.9	$	7.8
Other assets	$	4.9	$	17.0	Other liabilities	$	30.6	$	9.9

Derivative instruments not designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	1.6	$	2.1	Other accrued expenses and liabilities	$	2.0	$	2.2
Commodity derivative contracts:
Prepaid expenses and other	$	6.6	$	6.3	Other accrued expenses and liabilities	$	8.7	$	3.0
Other assets	$	1.7	$	2.8	Other liabilities	$	8.5	$	2.6

The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as Other Comprehensive Income (“OCI”), net of income tax effect, is as follows:



Derivative Instruments in Designated Cash Flow Hedging Relationships	Net Gain (Loss) Recognized in OCI			Location of Net Gain (Loss) Reclassified from AOCI to Income	Net Gain (Loss) Reclassified from AOCI to Income
(in millions)
For the Nine Months Ended November 30, 2018
Foreign currency contracts	$	(55.6	)	Sales	$	0.1
				Cost of product sold	5.2
	$	(55.6	)		$	5.3

For the Nine Months Ended November 30, 2017
Foreign currency contracts	$	44.5		Sales	$	(0.3	)
				Cost of product sold	0.3
Interest rate swap contracts	(1.5		)	Interest expense	1.3
	$	43.0			$	1.3

For the Three Months Ended November 30, 2018
Foreign currency contracts	$	(48.6	)	Sales	$	—
				Cost of product sold	0.5
	$	(48.6	)		$	0.5

For the Three Months Ended November 30, 2017
Foreign currency contracts	$	(22.1	)	Sales	$	(0.4	)
				Cost of product sold	2.3
Interest rate swap contracts	0.9			Interest expense	1.4
	$	(21.2	)		$	3.3

We expect $15.5 million of net losses, net of income tax effect, to be reclassified from accumulated other comprehensive income (loss) (“AOCI”) to our results of operations within the next 12 months.

The effect of our undesignated derivative instruments on our results of operations is as follows:



Derivative Instruments Not Designated as Hedging Instruments	Location of Net Gain (Loss) Recognized in Income	Net Gain (Loss) Recognized in Income
(in millions)
For the Nine Months Ended November 30, 2018
Commodity derivative contracts	Cost of product sold	$	(5.1	)
Foreign currency contracts	Selling, general and administrative expenses	(58.5		)
Interest rate swap contracts	Interest expense	35.0
		$	(28.6	)

For the Nine Months Ended November 30, 2017
Commodity derivative contracts	Cost of product sold	$	4.3
Foreign currency contracts	Selling, general and administrative expenses	4.4
		$	8.7

For the Three Months Ended November 30, 2018
Commodity derivative contracts	Cost of product sold	$	(14.7	)
Foreign currency contracts	Selling, general and administrative expenses	(30.4		)
Interest rate swap contracts	Interest expense	32.3
		$	(12.8	)

For the Three Months Ended November 30, 2017
Commodity derivative contracts	Cost of product sold	$	3.5
Foreign currency contracts	Selling, general and administrative expenses	(2.0		)
		$	1.5